Prakash Deedwania

Prakash Deedwania, MD

Professor of Clinical Medicine
Cardiology - Fresno
Publications: 

Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF.

JACC. Heart failure

Patel S, Raman VK, Faselis C, Fonarow GC, Lam PH, Ahmed AA, Heidenreich PA, Anker SD, Deedwania P, Morgan CJ, Zhang S, Moore H, Rangaswami J, Bakris G, Butler J, Sheriff HM, Allman RM, Zeng-Treitler Q, Wu WC, Ahmed A

Digoxin Discontinuation in Patients with HFrEF on Beta-Blockers: Implication for Future "Knock-Out Trials" in Heart Failure.

The American journal of medicine

Lam PH, Liu K, Ahmed AA, Butler J, Heidenreich PA, Anker MS, Faselis C, Deedwania P, Aronow WS, Kanonidis I, Masson R, Gill GS, Morgan CJ, Arundel C, Allman RM, Wu WC, Fonarow GC, Ahmed A

Global Community Health Screening and Educational Intervention for Early Detection of Cardiometabolic Renal Disease.

Annals of global health

Nabaty NL, Menon T, Trang G, Vijay A, Chogyal L, Cataldo R, Govind N, Jain P, Singh P, Dolasa N, Sahani M, Deedwania P, Vijayaraghavan K

Identification and outcomes of KDIGO-defined chronic kidney disease in 1.4 million U.S. Veterans with heart failure.

European journal of heart failure

Patel SS, Raman VK, Zhang S, Deedwania P, Zeng-Treitler Q, Wu WC, Lam PH, Bakris G, Moore H, Heidenreich PA, Rangaswami J, Morgan CJ, Cheng Y, Sheriff HM, Faselis C, Mehta RL, Anker SD, Fonarow GC, Ahmed A

Considerations Regarding Management of Heart Failure in Older Adults.

Cardiology in review

Alagiakrishnan K, Mah D, Aronow WS, Lam PH, Frishman WH, Ahmed A, Deedwania P

Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV.

Journal of clinical lipidology

Puri R, Bansal M, Mehta V, Duell PB, Wong ND, Iyengar SS, Kalra D, Nair DR, Nanda NC, Narula J, Deedwania P, Yusuf J, Dalal JJ, Shetty S, Vijan VM, Agarwala R, Kumar S, Vijay K, Khan A, Wander GS, Manoria PC, Wangnoo SK, Mohan V, Joshi SR, Singh B, Kerkar P, Rajput R, Prabhakar D, Zargar AH, Saboo B, Kasliwal RR, Ray S, Bansal S, Rabbani MU, Chhabra ST, Chandra S, Bardoloi N, Kavalipati N, Sathyamurthy I, Mahajan K, Pradhan A, Khanna NN, Khadgawat R, Gupta P, Chag MC, Gupta A, Murugnathan A, Narasingan SN, Upadhyaya S, Mittal V, Melinkeri RP, Yadav M, Mubarak MR, Pareek KK, Dabla PK, Nanda R, Mohan JC

Guideline-Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction.

Drugs

Patel J, Rassekh N, Fonarow GC, Deedwania P, Sheikh FH, Ahmed A, Lam PH

Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association.

Circulation

Kwan TW, Wong SS, Hong Y, Kanaya AM, Khan SS, Hayman LL, Shah SH, Welty FK, Deedwania PC, Khaliq A, Palaniappan LP, American Heart Association Council on Epidemiology and Prevention; Council on Lifestyle and Cardiome

Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease.

The American journal of medicine

Patel S, Lam PH, Kanonidis EI, Ahmed AA, Raman VK, Wu WC, Rossignol P, Arundel C, Faselis C, Kanonidis IE, Deedwania P, Allman RM, Sheikh FH, Fonarow GC, Pitt B, Ahmed A

Imaging Modality for Left Ventricular Ejection Fraction Estimation and Effect of Implantable Cardioverter Defibrillator on Mortality in Patients with Heart Failure.

Heart rhythm

Smith A, Kumar S, Moore HJ, Iskandrian AE, Nanda NC, Raman VK, Singh S, Fletcher RD, Deedwania P, Fonarow GC, Greenberg MD, Ahmed A, Lam PH

Risk of Stroke in Older Adults With Heart Failure.

The American journal of cardiology

Bierbower E, Griffith N, Raman VK, Brar V, Roseman J, Deedwania P, Fonarow GC, Allman RM, Faselis C, Zhang S, Howard G, Ahmed A, Lam PH

Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended.

JAMA oncology

Faselis C, Nations JA, Morgan CJ, Antevil J, Roseman JM, Zhang S, Fonarow GC, Sheriff HM, Trachiotis GD, Allman RM, Deedwania P, Zeng-Trietler Q, Taub DD, Ahmed AA, Howard G, Ahmed A

Initiation of anti-hypertensive drugs and outcomes in patients with heart failure with preserved ejection fraction and persistent hypertension.

Progress in cardiovascular diseases

Lam PH, Tsimploulis A, Patel S, Raman VK, Arundel C, Faselis C, Deedwania P, Sheikh FH, Banerjee SK, Allman RM, Fonarow GC, Aronow WS, Ahmed A

GLP-1 receptor agonists and cardiovascular outcomes in patients with type 2 diabetes: Clinical evidence and best practice.

Journal of the American Association of Nurse Practitioners

Coke LA, Deedwania PC, Hinnen D, Magwire M, Miller NH

Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association.

Circulation

Joseph JJ, Deedwania P, Acharya T, Aguilar D, Bhatt DL, Chyun DA, Di Palo KE, Golden SH, Sperling LS, American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health

In-Hospital Weight Loss and Outcomes in Patients With Heart Failure.

Journal of cardiac failure

Gill GS, Lam PH, Brar V, Patel S, Arundel C, Deedwania P, Faselis C, Allman RM, Zhang S, Morgan CJ, Fonarow GC, Ahmed A

Cardiovascular Impact of Race and Ethnicity in Patients With Diabetes and Obesity: JACC Focus Seminar 2/9.

Journal of the American College of Cardiology

Joseph JJ, Ortiz R, Acharya T, Golden SH, López L, Deedwania P

Beta-Blocker Use and Outcomes in Nursing Home Residents with Heart Failure with Reduced Ejection Fraction.

The American journal of medicine

Bayoumi E, Lam PH, Enders R, Arundel C, Sheriff HM, Brar V, Jurgens CY, Deedwania P, Faselis C, Allman RM, Fonarow GC, Ahmed A

Initiation of Anti-Hypertensive Drugs and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction.

The American journal of medicine

Lam PH, Aronow WS, Tsimploulis A, Bhyan P, Allam SD, Patel S, Raman VK, Arundel C, Sheikh FH, Kanonidis IE, Deedwania P, Allman RM, Fonarow GC, Faselis C, Ahmed A

Strategies for Promotion of a Healthy Lifestyle in Clinical Settings: Pillars of Ideal Cardiovascular Health: A Science Advisory From the American Heart Association.

Circulation

Kris-Etherton PM, Petersen KS, Després JP, Anderson CAM, Deedwania P, Furie KL, Lear S, Lichtenstein AH, Lobelo F, Morris PB, Sacks FM, Ma J

SGLT2 Inhibitors: The Dawn of a New Era in Cardio-Metabolic Therapeutics.

American journal of cardiovascular drugs : drugs, devices, and other interventions

Deedwania P

Right Ventricular Ejection Fraction and Beta-Blocker Effect in Heart Failure With Reduced Ejection Fraction.

Journal of cardiac failure

Lam PH, Keramida K, Filippatos GS, Gupta N, Faselis C, Deedwania P, George B, Iskandrian A, Cleland JG, Choudhary G, Wu WC, Morgan CJ, Fonarow GC, Ahmed A

Income disparity and incident cardiovascular disease in older Americans.

Progress in cardiovascular diseases

Faselis C, Safren L, Allman RM, Lam PH, Brar V, Morgan CJ, Ahmed AA, Deedwania P, Alagiakrishnan K, Sheikh FH, Fonarow GC, Ahmed A

Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects - A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial.

Circulation journal : official journal of the Japanese Circulation Society

Keech AC, Oyama K, Sever PS, Tang M, Murphy SA, Hirayama A, Lu C, Tay L, Deedwania PC, Siu CW, Lira Pineda A, Choi D, Charng MJ, Amerena J, Wan Ahmad WA, Chopra VK, Pedersen TR, Giugliano RP, Sabatine MS, FOURIER Study Group

Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy: Secondary Analysis From the FOURIER Randomized Clinical Trial.

JAMA cardiology

Deedwania P, Murphy SA, Scheen A, Badariene J, Pineda AL, Honarpour N, Keech AC, Sever PS, Pedersen TR, Sabatine MS, Giugliano RP

Loop Diuretic Prescription and Long-Term Outcomes in Heart Failure: Association Modification by Congestion.

The American journal of medicine

Faselis C, Lam PH, Patel S, Arundel C, Filippatos G, Deedwania P, Zile MR, Wopperer S, Nguyen T, Allman RM, Fonarow GC, Ahmed A

Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes.

American journal of cardiovascular drugs : drugs, devices, and other interventions

Kaul S, Gupta M, Bandyopadhyay D, Hajra A, Deedwania P, Roddy E, Mamas M, Klein A, Lavie CJ, Fonarow GC, Ghosh RK

Defining the Role of Icosapent Ethyl in Clinical Practice.

American journal of cardiovascular drugs : drugs, devices, and other interventions

Chatterjee S, Hajra A, Bandyopadhyay D, Ghosh RK, Deedwania PC

Impact of the 2017 ACC/AHA guidelines on the prevalence of hypertension among Indian adults: Results from a cross-sectional survey.

International Journal of Cardiology. Hypertension

Gupta K, Ramakrishnan S, Zachariah G, Rao JS, Mohanan PP, Venugopal K, Sateesh S, Sethi R, Jain D, Bardolei N, Mani K, Kakar TS, Jain V, Gupta P, Gupta R, Bansal S, Nath RK, Tyagi S, Wander GS, Gupta S, Mandal S, Senguttuvan NB, Subramanyam G, Roy D, Datta S, Ganguly K, Routray SN, Mishra SS, Singh BP, Bharti BB, Das MK, Deb PK, Deedwania P, Seth A, CSI-Great India BP Campaign Investigators

Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension.

The American journal of medicine

Faselis C, Lam PH, Zile MR, Bhyan P, Tsimploulis A, Arundel C, Patel S, Kokkinos P, Deedwania P, Bhatt DL, Zeng-Trietler Q, Morgan CJ, Aronow WS, Allman RM, Fonarow GC, Ahmed A

Evidence-Based Policy Making for Public Health Interventions in Cardiovascular Diseases: Formally Assessing the Feasibility of Clinical Trials.

Circulation. Cardiovascular quality and outcomes

Foti K, Foraker RE, Martyn-Nemeth P, Anderson CAM, Cook NR, Lichtenstein AH, de Ferranti SD, Young DR, Hivert MF, Ross R, Deedwania P, Whitsel LP, Appel LJ

Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure.

Journal of the American College of Cardiology

Faselis C, Arundel C, Patel S, Lam PH, Gottlieb SS, Zile MR, Deedwania P, Filippatos G, Sheriff HM, Zeng Q, Morgan CJ, Wopperer S, Nguyen T, Allman RM, Fonarow GC, Ahmed A

Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation.

The American journal of medicine

Singh S, Moore H, Karasik PE, Lam PH, Wopperer S, Arundel C, Tummala L, Anker MS, Faselis C, Deedwania P, Morgan CJ, Zeng Q, Allman RM, Fonarow GC, Ahmed A

Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association.

Circulation

Arnold SV, Bhatt DL, Barsness GW, Beatty AL, Deedwania PC, Inzucchi SE, Kosiborod M, Leiter LA, Lipska KJ, Newman JD, Welty FK, American Heart Association Council on Lifestyle and Cardiometabolic Health and Council on Clinical C

Association between depression and readmission of heart failure: A national representative database study.

Progress in cardiovascular diseases

Patel N, Chakraborty S, Bandyopadhyay D, Amgai B, Hajra A, Atti V, Das A, Ghosh RK, Deedwania PC, Aronow WS, Lavie CJ, Di Tullio MR, Vaduganathan M, Fonarow GC

Aspirin for Primary Prevention of Coronary Artery Disease.

Current problems in cardiology

Ujjawal A, Gupta M, Ghosh RK, Jain V, Bandyopadhyay D, Qamar A, Aronow WS, Deedwania P, Kapadia S, Lavie CJ

Therapeutic Inertia in Cardiovascular Disease Prevention: Time to Move the Bar.

Journal of the American College of Cardiology

Dixon DL, Sharma G, Sandesara PB, Yang E, Braun LT, Mensah GA, Sperling LS, Deedwania PC, Virani SS

Prevalence of hypertension among Indian adults: Results from the great India blood pressure survey.

Indian heart journal

Ramakrishnan S, Zachariah G, Gupta K, Shivkumar Rao J, Mohanan PP, Venugopal K, Sateesh S, Sethi R, Jain D, Bardolei N, Mani K, Kakar TS, Kidambi B, Bhushan S, Verma SK, Bhargava B, Roy A, Kothari SS, Gupta R, Bansal S, Sood S, Nath RK, Tyagi S, Gupta MD, Girish MP, Kalra IPS, Wander GS, Gupta S, Mandal S, Senguttuvan NB, Subramanyam G, Roy D, Datta S, Ganguly K, Routray SN, Mishra SS, Singh BP, Bharti BB, Das MK, Kumar S, Goswami KC, Bahl VK, Chandra S, Banerjee A, Guha S, Deb PK, Chopra HK, Deedwania P, Seth A, CSI-Great India BP Campaign Investigators

Sodium Glucose Co-transporter 2 Inhibitors and Heart Failure.

The American journal of cardiology

Ghosh RK, Ghosh GC, Gupta M, Bandyopadhyay D, Akhtar T, Deedwania P, Lavie CJ, Fonarow GC, Aneja A

Trends of Cardiac Complications in Patients With Rheumatoid Arthritis: Analysis of the United States National Inpatient Sample; 2005-2014.

Current problems in cardiology

Bandyopadhyay D, Banerjee U, Hajra A, Chakraborty S, Amgai B, Ghosh RK, Haddadin FI, Modi VA, Sinha K, Aronow WS, Deedwania P, Lavie CJ

Cardiovascular outcome trials of the newer anti-diabetic medications.

Progress in cardiovascular diseases

Acharya T, Deedwania P

An update on pharmacotherapies in diabetic dyslipidemia.

Progress in cardiovascular diseases

Gupta M, Tummala R, Ghosh RK, Blumenthal C, Philip K, Bandyopadhyay D, Ventura H, Deedwania P

Oral insulin: an update.

Minerva endocrinologica

Chatterjee S, Bhushan Sharma C, Lavie CJ, Adhikari A, Deedwania P, O'keefe JH

Alirocumab efficacy and safety by race and ethnicity: Analysis from 3 ODYSSEY phase 3 trials.

Journal of clinical lipidology

Ferdinand KC, Jacobson TA, Koren A, Elassal J, Thompson D, Deedwania P

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial.

Journal of the American College of Cardiology

Charytan DM, Sabatine MS, Pedersen TR, Im K, Park JG, Pineda AL, Wasserman SM, Deedwania P, Olsson AG, Sever PS, Keech AC, Giugliano RP, FOURIER Steering Committee and Investigators

Cardiovascular Protection with Anti-hyperglycemic Agents.

American journal of cardiovascular drugs : drugs, devices, and other interventions

Deedwania P, Acharya T

Cardiometabolic-Renal Disease in South Asians: Consensus Recommendations from the Cardio Renal Society of America.

Cardiorenal medicine

Vijayaraghavan K, McCullough PA, Singh B, Gupta M, Enas E, Mohan V, Misra A, Deedwania P, Brinton EA, for the Consensus Panel Steering Committee

Fish Oil and Cardiometabolic Diseases: Recent Updates and Controversies.

The American journal of medicine

Tummala R, Ghosh RK, Jain V, Devanabanda AR, Bandyopadhyay D, Deedwania P, Aronow WS

American Heart Association Diabetes and Cardiometabolic Health Summit: Summary and Recommendations.

Journal of the American Heart Association

Sasson C, Eckel R, Alger H, Bozkurt B, Carson A, Daviglus M, Deedwania P, Kirley K, Lamendola C, Nguyen M, Rajgopal Singh R, Wang T, Sanchez E

Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.

The American journal of medicine

Lam PH, Gupta N, Dooley DJ, Singh S, Deedwania P, Zile MR, Bhatt DL, Morgan CJ, Pitt B, Fonarow GC, Ahmed A

SGLT-2 Inhibitors and Peripheral Artery Disease: A Statistical Hoax or Reality?

Current problems in cardiology

Chatterjee S, Bandyopadhyay D, Ghosh RK, Majumdar U, Aneja A, Lavie CJ, Deedwania P

Obesity is rarely healthy.

The lancet. Diabetes & endocrinology

Lavie CJ, Deedwania P, Ortega FB

Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.

JAMA cardiology

Tsimploulis A, Lam PH, Arundel C, Singh SN, Morgan CJ, Faselis C, Deedwania P, Butler J, Aronow WS, Yancy CW, Fonarow GC, Ahmed A

25-Year trends in hypertension prevalence, awareness, treatment, and control in an Indian urban population: Jaipur Heart Watch.

Indian heart journal

Gupta R, Gupta VP, Prakash H, Agrawal A, Sharma KK, Deedwania PC

Olmesartan-based monotherapy vs combination therapy in hypertension: A meta-analysis based on age and chronic kidney disease status.

Journal of clinical hypertension (Greenwich, Conn.)

Deedwania P, Weber M, Reimitz PE, Bakris G

Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.

Journal of the American College of Cardiology

Lam PH, Dooley DJ, Deedwania P, Singh SN, Bhatt DL, Morgan CJ, Butler J, Mohammed SF, Wu WC, Panjrath G, Zile MR, White M, Arundel C, Love TE, Blackman MR, Allman RM, Aronow WS, Anker SD, Fonarow GC, Ahmed A

Hearty Breakfast for Healthier Arteries.

Journal of the American College of Cardiology

Deedwania P, Acharya T

Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.

European journal of heart failure

Lam PH, Dooley DJ, Fonarow GC, Butler J, Bhatt DL, Filippatos GS, Deedwania P, Forman DE, White M, Fletcher RD, Arundel C, Blackman MR, Adamopoulos C, Kanonidis IE, Aban IB, Patel K, Aronow WS, Allman RM, Anker SD, Pitt B, Ahmed A

Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial.

The lancet. Diabetes & endocrinology

Sabatine MS, Leiter LA, Wiviott SD, Giugliano RP, Deedwania P, De Ferrari GM, Murphy SA, Kuder JF, Gouni-Berthold I, Lewis BS, Handelsman Y, Pineda AL, Honarpour N, Keech AC, Sever PS, Pedersen TR

Treatment of systolic hypertension and low diastolic blood pressure in older adults: How low is too low?!

International journal of cardiology

Tsimploulis A, Sheriff HM, Anker MS, Deedwania P, Fletcher RD, Aronow WS, Anker SD, Ahmed A

Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure.

Journal of the American Medical Directors Association

Sheriff HM, Thogaripally MR, Panjrath G, Arundel C, Zeng Q, Fonarow GC, Butler J, Fletcher RD, Morgan C, Blackman MR, Deedwania P, Love TE, Aronow WS, Anker SD, Allman RM, Ahmed A

Corrigendum to "Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study" [Int. J. Cardiol. 235 (2017) 11-16].

International journal of cardiology

Tsimploulis A, Sheriff HM, Lam PH, Dooley DJ, Anker MS, Papademetriou V, Fletcher RD, Faselis C, Fonarow GC, Deedwania P, White M, Valentova M, Blackman MR, Banach M, Morgan CJ, Alagiakrishnan K, Allman RM, Aronow WS, Anker SD, Ahmed A

Updated risk factors should be used to predict development of diabetes.

Journal of diabetes and its complications

Bethel MA, Hyland KA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Levitt NS, McMurray JJV, Boutati E, Thomas L, Sun JL, Haffner SM, NAVIGATOR Study Group

Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study.

International journal of cardiology

Sheriff HM, Tsimploulis A, Valentova M, Anker MS, Deedwania P, Banach M, Morgan CJ, Blackman MR, Fonarow GC, White M, Alagiakrishnan K, Allman RM, Aronow WS, Anker SD, Ahmed A

Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study.

International journal of cardiology

Tsimploulis A, Sheriff HM, Lam PH, Dooley DJ, Anker MS, Papademetriou V, Fletcher RD, Faselis C, Fonarow GC, Deedwania P, White M, Valentova M, Blackman MR, Banach M, Morgan CJ, Alagiakrishnan K, Allman RM, Aronow WS, Anker SD, Ahmed A

Compliance with guideline-directed therapy in diabetic patients admitted with acute coronary syndrome: Findings from the American Heart Association's Get With The Guidelines-Coronary Artery Disease (GWTG-CAD) program.

American heart journal

Deedwania P, Acharya T, Kotak K, Fonarow GC, Cannon CP, Laskey WK, Peacock WF, Pan W, Bhatt DL, GWTG Steering Committee and Investigators

Anticoagulation in Atrial Fibrillation: Is the Paradigm Really Shifting?

Journal of the American College of Cardiology

Deedwania P, Acharya T

Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone.

International journal of cardiology

Lam PH, Dooley DJ, Inampudi C, Arundel C, Fonarow GC, Butler J, Wu WC, Blackman MR, Anker MS, Deedwania P, White M, Prabhu SD, Morgan CJ, Love TE, Aronow WS, Allman RM, Ahmed A

Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes.

International journal of cardiology

Deedwania PC, Pedersen TR, DeMicco DA, Breazna A, Betteridge DJ, Hitman GA, Durrington P, Neil A, TNT, CARDS and IDEAL Steering Committees and Investigators

Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure.

The American journal of medicine

Arundel C, Lam PH, Khosla R, Blackman MR, Fonarow GC, Morgan C, Zeng Q, Fletcher RD, Butler J, Wu WC, Deedwania P, Love TE, White M, Aronow WS, Anker SD, Allman RM, Ahmed A

Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.

The American journal of medicine

Sanam K, Bhatia V, Bajaj NS, Gaba S, Morgan CJ, Fonarow GC, Butler J, Deedwania P, Prabhu SD, Wu WC, White M, Love TE, Aronow WS, Fletcher RD, Allman RM, Ahmed A

Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study).

The American journal of cardiology

Shepherd J, Breazna A, Deedwania PC, LaRosa JC, Wenger NK, Messig M, Wilson DJ, Treating to New Targets Steering Committee and Investigators

Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study.

Diabetes, obesity & metabolism

Deedwania PC, Shepherd J, Breazna A, DeMicco DA, Treating to New Targets (TNT) Steering Committee Investigators

Frequent Atrial Premature Complexes and Their Association With Risk of Atrial Fibrillation.

The American journal of cardiology

Acharya T, Tringali S, Bhullar M, Nalbandyan M, Ilineni VK, Carbajal E, Deedwania P

Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology.

Journal of the American College of Cardiology

Morris PB, Ference BA, Jahangir E, Feldman DN, Ryan JJ, Bahrami H, El-Chami MF, Bhakta S, Winchester DE, Al-Mallah MH, Sanchez Shields M, Deedwania P, Mehta LS, Phan BA, Benowitz NL

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.

Journal of clinical lipidology

Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, La Forge R, Daniels SR, Wilson DP, Morris PB, Wild RA, Grundy SM, Daviglus M, Ferdinand KC, Vijayaraghavan K, Deedwania PC, Aberg JA, Liao KP, McKenney JM, Ross JL, Braun LT, Ito MK, Bays HE, Brown WV, Underberg JA, NLA Expert Panel

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

Diabetes care

Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK, American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascu, American Diabetes Association

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.

Circulation

Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK, American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health

Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial.

European journal of heart failure

Anker SD, Kosiborod M, Zannad F, Piña IL, McCullough PA, Filippatos G, van der Meer P, Ponikowski P, Rasmussen HS, Lavin PT, Singh B, Yang A, Deedwania P

Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking.

Circulation. Heart failure

Ahmed AA, Patel K, Nyaku MA, Kheirbek RE, Bittner V, Fonarow GC, Filippatos GS, Morgan CJ, Aban IB, Mujib M, Desai RV, Allman RM, White M, Deedwania P, Howard G, Bonow RO, Fletcher RD, Aronow WS, Ahmed A

Geographic epidemiology of cardiometabolic risk factors in middle class urban residents in India: cross-sectional study.

Journal of global health

Gupta R, Sharma KK, Gupta BK, Gupta A, Saboo B, Maheshwari A, Mahanta T, Deedwania PC

Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation.

The International journal of angiology : official publication of the International College of Angiology, Inc

Aftab W, Gazallo J, Motabar A, Varadrajan P, Deedwania PC, Pai RG

Low Prevalence of AHA-Defined Ideal Cardiovascular Health Factors: A Study of Urban Indian Men and Women.

Global heart

Gupta B, Gupta R, Sharma KK, Gupta A, Mahanta TG, Deedwania PC

Gaps in guideline implementation: a cause for concern, time for action.

Journal of the American College of Cardiology

Deedwania P

Management of Patients With Stable Angina and Type 2 Diabetes.

Reviews in cardiovascular medicine

Deedwania PC

Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.

The American journal of medicine

Bhatia V, Bajaj NS, Sanam K, Hashim T, Morgan CJ, Prabhu SD, Fonarow GC, Deedwania P, Butler J, Carson P, Love TE, Kheirbek R, Aronow WS, Anker SD, Waagstein F, Fletcher R, Allman RM, Ahmed A

Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers.

PloS one

Arsenault BJ, Barter P, DeMicco DA, Bao W, Preston GM, LaRosa JC, Grundy SM, Deedwania P, Greten H, Wenger NK, Shepherd J, Waters DD, Kastelein JJ, Treating to New Targets (TNT) Investigators

Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST).

Circulation. Heart failure

Jones LG, Sin MK, Hage FG, Kheirbek RE, Morgan CJ, Zile MR, Wu WC, Deedwania P, Fonarow GC, Aronow WS, Prabhu SD, Fletcher RD, Ahmed A, Allman RM

Prevalence of diabetes and cardiovascular risk factors in middle-class urban participants in India.

BMJ open diabetes research & care

Gupta A, Gupta R, Sharma KK, Lodha S, Achari V, Asirvatham AJ, Bhansali A, Gupta B, Gupta S, Jali MV, Mahanta TG, Maheshwari A, Saboo B, Singh J, Deedwania PC

Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.

The American journal of medicine

Kumbhani DJ, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Deedwania P, Grau-Sepulveda M, Schwamm LH, Bhatt DL, Get With the Guidelines Steering Committee and Investigators

Reply: To PMID 24846806.

The American journal of cardiology

Inampudi C, Deedwania P, Fonarow GC, Sanders PW, Aronow WS, Ahmed A

Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease.

The American journal of medicine

Böhm M, Reil JC, Deedwania P, Kim JB, Borer JS

Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction.

Circulation. Heart failure

Patel K, Fonarow GC, Ahmed M, Morgan C, Kilgore M, Love TE, Deedwania P, Aronow WS, Anker SD, Ahmed A

Racial differences in mortality in patients with advanced systolic heart failure: potential role of right ventricular ejection fraction.

International journal of cardiology

White M, Patel K, Caldentey G, Deedwania P, Kheirbek R, Fletcher RD, Aban IB, Lo A, Aronow WS, Fonarow GC, Anker SD, Ahmed A

Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults.

The American journal of cardiology

Bajaj NS, Bhatia V, Sanam K, Ather S, Hashim T, Morgan C, Fonarow GC, Nanda NC, Prabhu SD, Adamopoulos C, Kheirbek R, Aronow WS, Fletcher RD, Anker SD, Ahmed A, Deedwania P

High prevalence of metabolic syndrome among urban subjects in India: a multisite study.

Diabetes & metabolic syndrome

Deedwania PC, Gupta R, Sharma KK, Achari V, Gupta B, Maheshwari A, Gupta A

Spironolactone use and higher hospital readmission for Medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m(2.).

The American journal of cardiology

Inampudi C, Parvataneni S, Morgan CJ, Deedwania P, Fonarow GC, Sanders PW, Prabhu SD, Butler J, Forman DE, Aronow WS, Allman RM, Ahmed A

Cholesterol lipoproteins and prevalence of dyslipidemias in urban Asian Indians: a cross sectional study.

Indian heart journal

Guptha S, Gupta R, Deedwania P, Bhansali A, Maheshwari A, Gupta A, Gupta B, Saboo B, Singh J, Achari V, Sharma KK

Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure.

The American journal of medicine

Ahmed A, Bourge RC, Fonarow GC, Patel K, Morgan CJ, Fleg JL, Aban IB, Love TE, Yancy CW, Deedwania P, van Veldhuisen DJ, Filippatos GS, Anker SD, Allman RM

Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.

The American journal of medicine

Bangalore S, Fayyad R, Laskey R, Demicco DA, Deedwania P, Kostis JB, Messerli FH, Treating to New Targets Steering Committee and Investigators

Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial.

European heart journal

Bangalore S, Fayyad R, Laskey R, DeMicco D, Deedwania P, Kostis JB, Messerli FH, Treating to New Targets Steering Committee and Investigators

Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study.

International journal of cardiology

Deedwania P, Patel K, Fonarow GC, Desai RV, Zhang Y, Feller MA, Ovalle F, Love TE, Aban IB, Mujib M, Ahmed MI, Anker SD, Ahmed A

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.

The American journal of cardiology

Bethel MA, Chacra AR, Deedwania P, Fulcher GR, Holman RR, Jenssen T, Kahn SE, Levitt NS, McMurray JJ, Califf RM, Raptis SA, Thomas L, Sun JL, Haffner SM

Diabetes, cardiovascular disease, and ethnicity.

Journal of the American College of Cardiology

Deedwania P

Primary Prevention of Atrial Fibrillation - The Path Untread.

Journal of atrial fibrillation

Lardizabal JA, Deedwania PC

Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes.

Journal of clinical hypertension (Greenwich, Conn.)

Deedwania P, Shea J, Chen W, Brener L

New oral anticoagulants in elderly patients with atrial fibrillation.

The American journal of medicine

Deedwania PC

Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control.

American journal of hypertension

Gupta R, Deedwania PC, Achari V, Bhansali A, Gupta BK, Gupta A, Mahanta TG, Asirvatham AJ, Gupta S, Maheshwari A, Saboo B, Jali MV, Singh J, Guptha S, Sharma KK

Ivabradine in heart failure: hope or hype?

American journal of cardiovascular drugs : drugs, devices, and other interventions

Deedwania PC

Prediabetes and the risk of diabetes.

Lancet (London, England)

Deedwania P, Ahmed A

β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.

JAMA

Bangalore S, Steg G, Deedwania P, Crowley K, Eagle KA, Goto S, Ohman EM, Cannon CP, Smith SC, Zeymer U, Hoffman EB, Messerli FH, Bhatt DL, REACH Registry Investigators

Evidence-based therapy for heart failure.

The Medical clinics of North America

Deedwania PC, Carbajal E

Heart failure: a common and complex clinical syndrome.

The Medical clinics of North America

Deedwania PC

The epidemiology and pathophysiology of heart failure.

The Medical clinics of North America

Rathi S, Deedwania PC

Association of educational, occupational and socioeconomic status with cardiovascular risk factors in Asian Indians: a cross-sectional study.

PloS one

Gupta R, Deedwania PC, Sharma K, Gupta A, Guptha S, Achari V, Asirvatham AJ, Bhansali A, Gupta B, Gupta S, Jali MV, Mahanta TG, Maheshwari A, Saboo B, Singh J, Gupta R

Atrial fibrillation in heart failure.

The Medical clinics of North America

Lardizabal JA, Deedwania PC

Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide?

Journal of clinical hypertension (Greenwich, Conn.)

Deedwania PC, Zappe DH, Egan BM, Purkayastha D, Samuel R, Sowers JR

Regional variations in cardiovascular risk factors in India: India heart watch.

World journal of cardiology

Gupta R, Guptha S, Sharma KK, Gupta A, Deedwania P

Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study.

Circulation

Mora S, Wenger NK, Demicco DA, Breazna A, Boekholdt SM, Arsenault BJ, Deedwania P, Kastelein JJ, Waters DD

Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study).

The American journal of cardiology

Ho JE, Waters DD, Kean A, Wilson DJ, Demicco DA, Breazna A, Wun CC, Deedwania PC, Khush KK, TNT Investigators

Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease program.

Circulation. Cardiovascular quality and outcomes

Qian F, Ling FS, Deedwania P, Hernandez AF, Fonarow GC, Cannon CP, Peterson ED, Peacock WF, Kaltenbach LA, Laskey WK, Schwamm LH, Bhatt DL, Get With The Guidelines Steering Committee and Investigators

Polymorphisms and noncardioembolic stroke in three case-control studies.

Cerebrovascular diseases (Basel, Switzerland)

Luke MM, Berger K, Rowland CM, Catanese JJ, Tong CH, Ross DA, Garcia V, Kuhlenbaeumer G, Ringelstein EB, Pullinger CR, Malloy MJ, Deedwania P, Ellis SG, Kane JP, Devlin JJ, Lalouschek W, Mannhalter C

The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies.

Circulation. Cardiovascular genetics

Arsenault BJ, Boekholdt SM, Hovingh GK, Hyde CL, DeMicco DA, Chatterjee A, Barter P, Deedwania P, Waters DD, LaRosa JC, Pedersen TR, Kastelein JJ, TNT and IDEAL Investigators

Twenty-year trends in cardiovascular risk factors in India and influence of educational status.

European journal of preventive cardiology

Gupta R, Guptha S, Gupta VP, Agrawal A, Gaur K, Deedwania PC

A propensity-matched study of the association of diabetes mellitus with incident heart failure and mortality among community-dwelling older adults.

The American journal of cardiology

Roy B, Pawar PP, Desai RV, Fonarow GC, Mujib M, Zhang Y, Feller MA, Ovalle F, Aban IB, Love TE, Iskandrian AE, Deedwania P, Ahmed A

Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease.

The American journal of cardiology

Guey LT, Pullinger CR, Ishida BY, O'Connor PM, Zellner C, Francone OL, Laramie JM, Naya-Vigne JM, Siradze KA, Deedwania P, Redberg RF, Frost PH, Seymour AB, Kane JP, Malloy MJ

Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.

American journal of cardiovascular drugs : drugs, devices, and other interventions

Deedwania PC, Huang GW

Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving β-blockers: insights from the BEST trial.

International journal of cardiology

Desai RV, Guichard JL, Mujib M, Ahmed MI, Feller MA, Fonarow GC, Meyer P, Iskandrian AE, Bogaard HJ, White M, Aban IB, Aronow WS, Deedwania P, Waagstein F, Ahmed A

Right ventricular ejection fraction <20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients.

International journal of cardiology

Meyer P, Desai RV, Mujib M, Feller MA, Adamopoulos C, Banach M, Lainscak M, Aban I, White M, Aronow WS, Deedwania P, Iskandrian AE, Ahmed A

Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure.

European journal of heart failure

Deedwania PC, Ahmed MI, Feller MA, Aban IB, Love TE, Pitt B, Ahmed A

Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension.

Current medical research and opinion

Fonseca V, Sharma PP, Shah M, Deedwania P

Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure.

The American journal of cardiology

Banach M, Bhatia V, Feller MA, Mujib M, Desai RV, Ahmed MI, Guichard JL, Aban I, Love TE, Aronow WS, White M, Deedwania P, Fonarow G, Ahmed A

Interventions for cardiovascular disease prevention.

Cardiology clinics

Gupta R, Deedwania P

The anti-ischemic and anti-anginal properties of statins.

Current atherosclerosis reports

Lardizabal JA, Deedwania PC

Rheumatic heart disease and risk of incident heart failure among community-dwelling older adults: a prospective cohort study.

Annals of medicine

Mujib M, Desai RV, Ahmed MI, Guichard JL, Feller MA, Ekundayo OJ, Deedwania P, Ali M, Aban IB, Love TE, White M, Aronow WS, Rahimtoola SH, Bonow RO, Ahmed A

Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers.

Journal of the American College of Cardiology

Arsenault BJ, Barter P, DeMicco DA, Bao W, Preston GM, LaRosa JC, Grundy SM, Deedwania P, Greten H, Wenger NK, Shepherd J, Waters DD, Kastelein JJ, TNT Study Investigators

Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves.

The American journal of cardiology

Mujib M, Rahman AA, Desai RV, Ahmed MI, Feller MA, Aban I, Love TE, White M, Deedwania P, Aronow WS, Fonarow G, Ahmed A

Low high-density lipoprotein cholesterol: current status and future strategies for management.

Vascular health and risk management

Singh V, Sharma R, Kumar A, Deedwania P

Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched study.

International journal of cardiology

Ahmed MI, Mujib M, Desai RV, Feller MA, Daniel C, Aban IB, Love TE, Deedwania P, Pitt B, Aronow WS, Ahmed A

Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study.

European journal of heart failure

Adamopoulos C, Meyer P, Desai RV, Karatzidou K, Ovalle F, White M, Aban I, Love TE, Deedwania P, Anker SD, Ahmed A

Benefits of statin therapy and compliance in high risk cardiovascular patients.

Vascular health and risk management

Lardizabal JA, Deedwania PC

Hypertension as a cardiometabolic risk.

Indian heart journal

Srikanth S, Deedwania P

Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives.

Journal of hypertension

Sowers JR, Raij L, Jialal I, Egan BM, Ofili EO, Samuel R, Zappe DH, Purkayastha D, Deedwania PC

Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial).

The American journal of cardiology

Desai RV, Banach M, Ahmed MI, Mujib M, Aban I, Love TE, White M, Fonarow G, Deedwania P, Aronow WS, Ahmed A

Effect of nateglinide on the incidence of diabetes and cardiovascular events.

The New England journal of medicine

NAVIGATOR Study Group, Holman RR, Haffner SM, McMurray JJ, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E, Ilkova H, Jenssen T, Kahn SE, Krum H, Laakso M, Leiter LA, Levitt NS, Mareev V, Martinez F, Masson C, Mazzone T, Meaney E, Nesto R, Pan C, Prager R, Raptis SA, Rutten GE, Sandstroem H, Schaper F, Scheen A, Schmitz O, Sinay I, Soska V, Stender S, Tamás G, Tognoni G, Tuomilehto J, Villamil AS, Vozár J, Califf RM

Effect of valsartan on the incidence of diabetes and cardiovascular events.

The New England journal of medicine

NAVIGATOR Study Group, McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E, Ilkova H, Jenssen T, Kahn SE, Krum H, Laakso M, Leiter LA, Levitt NS, Mareev V, Martinez F, Masson C, Mazzone T, Meaney E, Nesto R, Pan C, Prager R, Raptis SA, Rutten GE, Sandstroem H, Schaper F, Scheen A, Schmitz O, Sinay I, Soska V, Stender S, Tamás G, Tognoni G, Tuomilehto J, Villamil AS, Vozár J, Califf RM

Atrial fibrillation in heart failure: a comprehensive review.

The American journal of medicine

Deedwania PC, Lardizabal JA

The current state of beta blockers in hypertension therapy.

Indian heart journal

Lardizabal JA, Deedwania PC

Comparison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event (from the Treating to New Targets [TNT] trial).

The American journal of cardiology

LaRosa JC, Deedwania PC, Shepherd J, Wenger NK, Greten H, DeMicco DA, Breazna A, TNT Investigators

Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population.

Diabetic medicine : a journal of the British Diabetic Association

Bethel MA, Deedwania P, Levitt NS, Schmitz O, Huntsman-Labed A, Califf RM, Haffner SM, Diem P, NAVIGATOR Study Group

Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.

Vascular health and risk management

Sharma KK, Gupta R, Agrawal A, Roy S, Kasliwal A, Bana A, Tongia RK, Deedwania PC

An overview of glycemic control in the coronary care unit with recommendations for clinical management.

Journal of diabetes science and technology

Kosiborod M, Deedwania P

Beta-adrenergic blockers for chronic heart failure.

Cardiology in review

Javed U, Deedwania PC

Reducing morbidity and mortality in high risk patients with statins.

Vascular health and risk management

Singh V, Deedwania P

Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial.

Journal of the American Society of Hypertension : JASH

Fonarow GC, Deedwania P, Fonseca V, Nesto RW, Watson K, Tarka E, Lukas MA, Madan A, Shabbout M

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology

Journal of the American College of Cardiology

Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS, American Diabetes Association, American College of Cardiology Foundation, American Heart Association

Getting with the ACC/AHA guidelines for the treatment of chronic angina as a disease state.

Reviews in cardiovascular medicine

Deedwania PC, Carbajal EV

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology

Circulation

Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS, American Diabetes Association, American College of Cardiology Foundation, American Heart Association

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology

Diabetes care

Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS, American Diabetes Association, American College of Cardiology Foundation, American Heart Association

Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome.

Journal of clinical hypertension (Greenwich, Conn.)

Zappe DH, Sowers JR, Hsueh WA, Haffner SM, Deedwania PC, Fonseca VA, Keeling L, Sica DA

Statins in heart failure.

Cardiology clinics

Deedwania PC, Javed U

Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.

American heart journal

Sachdeva A, Cannon CP, Deedwania PC, Labresh KA, Smith SC, Dai D, Hernandez A, Fonarow GC

Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?

The American journal of cardiology

Ram CV, Deedwania PC

Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease.

Mayo Clinic proceedings

Shepherd J, Kastelein JP, Bittner VA, Carmena R, Deedwania PC, Breazna A, Dobson S, Wilson DJ, Zuckerman AL, Wenger NK, Treating to New Targets Steering Committee and Investigators

Ambulatory ECG-based T-wave alternans predicts sudden cardiac death in high-risk post-MI patients with left ventricular dysfunction in the EPHESUS study.

Journal of cardiovascular electrophysiology

Stein PK, Sanghavi D, Domitrovich PP, Mackey RA, Deedwania P

Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.

Circulation

Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, Deedwania P, Olsson AG, Boekholdt SM, Demicco DA, Szarek M, LaRosa JC, Pedersen TR, Grundy SM, TNT Study Group, IDEAL Study Group

Expanding roles for atorvastatin.

Drugs of today (Barcelona, Spain : 1998)

Singh V, Deedwania P

The benefits of intensive lipid lowering in patients with stable coronary heart disease with normal or high systolic blood pressure: an analysis of the Treating to New Targets (TNT) study.

Journal of clinical hypertension (Greenwich, Conn.)

Kostis JB, Breazna A, Deedwania PC, LaRosa JC, Treating to New Targets Steering Committee and Investigators

Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.

Journal of the American College of Cardiology

Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK, TNT (Treating to New Targets) Investigators

Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.

Circulation

Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P, American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Me

Diabetes and vascular disease.

Expert review of cardiovascular therapy

Deedwania P, Srikanth S

Obesity is major determinant of coronary risk factors in India: Jaipur Heart Watch studies.

Indian heart journal

Gupta R, Gupta VP, Bhagat N, Rastogi P, Sarna M, Prakash H, Deedwania PC

2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to devel

Journal of the American College of Cardiology

Fraker TD, Fihn SD, 2002 Chronic Stable Angina Writing Committee, American College of Cardiology, American Heart Association, Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Smith SC, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW

2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to devel

Circulation

Fraker TD, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Smith SC, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW, American College of Cardiology, American Heart Association, American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing

Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study.

Clinical journal of the American Society of Nephrology : CJASN

Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, Wilson DJ, Zuckerman A, Wenger NK, Treating to New Targets Investigators

Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials.

Stroke

Ford GA, Choy AM, Deedwania P, Karalis DG, Lindholm CJ, Pluta W, Frison L, Olsson SB, SPORTIF III, V Investigators

Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial).

The American journal of cardiology

Deedwania PC, Gupta M, Stein M, Ycas J, Gold A, IRIS Study Group

Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments.

Circulation

Kosiborod M, Soto GE, Jones PG, Krumholz HM, Weintraub WS, Deedwania P, Spertus JA

Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE).

Circulation

Deedwania P, Stone PH, Bairey Merz CN, Cosin-Aguilar J, Koylan N, Luo D, Ouyang P, Piotrowicz R, Schenck-Gustafsson K, Sellier P, Stein JH, Thompson PL, Tzivoni D

Clinical efficacy and cost-effectiveness of rosuvastatin.

Expert review of pharmacoeconomics & outcomes research

Deedwania PC, Smith DG

Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study.

Circulation

Khush KK, Waters DD, Bittner V, Deedwania PC, Kastelein JJ, Lewis SJ, Wenger NK

Diastolic dysfunction and autonomic abnormalities in patients with systolic heart failure.

European journal of heart failure

Stein PK, Tereshchenko L, Domitrovich PP, Kleiger RE, Perez A, Deedwania P

Management issues in the metabolic syndrome.

The Journal of the Association of Physicians of India

Deedwania PC, Gupta R

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.

Lancet (London, England)

Deedwania P, Barter P, Carmena R, Fruchart JC, Grundy SM, Haffner S, Kastelein JJ, LaRosa JC, Schachner H, Shepherd J, Waters DD, Treating to New Targets Investigators

Angiotensin receptor blockers: Cardiovascular protection in the metabolic syndrome.

Journal of the renin-angiotensin-aldosterone system : JRAAS

Deedwania PC, Schmieder R

Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study.

Diabetes care

Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Haffner S, Hsia J, Breazna A, LaRosa J, Grundy S, Waters D

Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.

Journal of cardiac failure

Caro JJ, Migliaccio-Walle K, O'Brien JA, Nova W, Kim J, Hauch O, Hillson E, Wedel H, Hjalmarson A, Gottlieb S, Deedwania PC, Wikstrand J, MERIT-HF Study Group

Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm.

The American journal of medicine

Deedwania PC, Fonseca VA

Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.

The American journal of cardiology

Davidson MH, Maki KC, Pearson TA, Pasternak RC, Deedwania PC, McKenney JM, Fonarow GC, Maron DJ, Ansell BJ, Clark LT, Ballantyne CM

Current Treatment Options for the Metabolic Syndrome.

Current treatment options in cardiovascular medicine

Deedwania PC, Volkova N

Dyslipidemia and lipid-lowering therapy in the elderly.

Expert review of cardiovascular therapy

Deedwania P, Volkova N

Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome.

The American journal of cardiology

Deedwania PC, Hunninghake DB, Bays HE, Jones PH, Cain VA, Blasetto JW, STELLAR Study Group

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).

Journal of the American College of Cardiology

Gullestad L, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, Gottlieb S, Rashkow A, Wedel H, Bermann G, Kjekshus J, MERIT-HF Study Group

Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.

American heart journal

Deedwania PC, Giles TD, Klibaner M, Ghali JK, Herlitz J, Hildebrandt P, Kjekshus J, Spinar J, Vitovec J, Stanbrook H, Wikstrand J, MERIT-HF Study Group

Consistency of the beneficial effect of metoprolol succinate extended release across a wide range dose of angiotensin-converting enzyme inhibitors and digitalis.

Journal of cardiac failure

Ghali JK, Dunselman P, Waagstein F, Goldstein S, Gottlieb SS, Deedwania PC, Wikstrand JC

Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications.

Cardiology clinics

Mensah GA, Mokdad AH, Ford E, Narayan KM, Giles WH, Vinicor F, Deedwania PC

Prevalence of metabolic syndrome in an Indian urban population.

International journal of cardiology

Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K

Treating dyslipidemia in high-risk patients: case reviews and discussion.

Postgraduate medicine

Deedwania PC, Davidson MH, Ballantyne CM

Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure.

European heart journal

Deedwania PC, Gottlieb S, Ghali JK, Waagstein F, Wikstrand JC, MERIT-HF Study Group

Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome.

The American journal of cardiology

Deedwania PC, Hunninghake DB, Bays H

A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.

Journal of cardiac failure

Domanski MJ, Krause-Steinrauf H, Massie BM, Deedwania P, Follmann D, Kovar D, Murray D, Oren R, Rosenberg Y, Young J, Zile M, Eichhorn E, BEST Investigators

The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial.

Journal of the American College of Cardiology

Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, Haffner S, Katz R, Lindenfeld J, Lowes BD, Martin W, McGrew F, Bristow MR, BEST Investigators

How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).

Cardiac electrophysiology review

Wikstrand J, Wedel H, Ghali J, Deedwania P, Fagerberg B, Goldstein S, Gottlieb S, Hjalmarson A, Kjekshus J, Waagstein F

Metoprolol CR/XL in black patients with heart failure (from the Metoprolol CR/XL randomized intervention trial in chronic heart failure).

The American journal of cardiology

Goldstein S, Deedwania P, Gottlieb S, Wikstrand J, MERIT-HF Study Group

Increased variance in blood pressure distribution and changing hypertension prevalence in an urban Indian population.

Journal of human hypertension

Gupta R, Sharma AK, Gupta VP, Bhatnagar S, Rastogi S, Deedwania PC

The rational use of diuretics in heart failure.

Current cardiology reports

Ravnan SL, Deedwania PC

ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients

Circulation

Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Gibbons RJ, Alpert JS, Antman EM, Hiratzka LF, Fuster V, Faxon DP, Gregoratos G, Jacobs AK, Smith SC, American College of Cardiology, American Heart Association Task Force on Practice Guidelines. Committee on the Management of Patient

ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients

Journal of the American College of Cardiology

Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, American College of Cardiology, American Heart Association Task Force on practice guidelines (Committee on the Management of Patient

Prevention of and medical therapy for atrial arrhythmias in heart failure.

Heart failure reviews

Khand AU, Cleland JG, Deedwania PC

Treating hypertension in patients with diabetes.

The Nurse practitioner

Reynolds HQ, Deedwania PC

Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory.

Journal of the American College of Cardiology

Kerensky RA, Wade M, Deedwania P, Boden WE, Pepine CJ, Veterans Affairs Non-Q-Wave Infarction Stategies in-Hospital (VANQWISH) Trial Investigators

Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study).

American heart journal

Spertus JA, Tooley J, Jones P, Poston C, Mahoney E, Deedwania P, Hurley S, Pitt B, Weintraub WS

Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF).

Circulation

Gottlieb SS, Fisher ML, Kjekshus J, Deedwania P, Gullestad L, Vitovec J, Wikstrand J, MERIT-HF Investigators

Clinical significance of cardiovascular dysmetabolic syndrome.

Current controlled trials in cardiovascular medicine

Deedwania PC

Ambulatory electrocardiographic monitoring for myocardial ischemia.

Current problems in cardiology

Deedwania PC, Stone PH

Pharmacotherapy of hypertension in patients with diabetes mellitus.

Expert opinion on pharmacotherapy

Deedwania PC

Global risk assessment in the presymptomatic patient.

The American journal of cardiology

Deedwania P

Fractal and complexity measures of heart rate dynamics after acute myocardial infarction.

The American journal of cardiology

Perkiömäki JS, Zareba W, Ruta J, Dubner S, Madoery C, Deedwania P, Karcz M, Bayes de Luna A, IDEAL Investigators

Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.

American heart journal

Wedel H, Demets D, Deedwania P, Fagerberg B, Goldstein S, Gottlieb S, Hjalmarson A, Kjekshus J, Waagstein F, Wikstrand J, MERIT-HF Study Group

Silent ischemia predicts poor outcome in high-risk healthy men.

Journal of the American College of Cardiology

Deedwania PC

Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function.

Journal of cardiovascular pharmacology and therapeutics

Sun YP, Zhu BQ, Browne AE, Pulukurthy S, Chou TM, Sudhir K, Glantz SA, Deedwania PC, Chatterjee K, Parmley WW

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.

JAMA

Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, McNamara JR, Kashyap ML, Hershman JM, Wexler LF, Rubins HB, VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial

Atrial fibrillation in patients with heart failure: pharmacologic options.

Congestive heart failure (Greenwich, Conn.)

Matalka MS, Deedwania PC

Coronary heart disease and risk factors in Asian Indians.

Advances in experimental medicine and biology

Chandalia M, Deedwania PC

Mechanism of the deadly quartet.

The Canadian journal of cardiology

Deedwania PC

Hypertension and diabetes: new therapeutic options.

Archives of internal medicine

Deedwania PC

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

JAMA

Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vítovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Jánosi A, Thorgeirsson G, Dunselman PH, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P

Endothelium: a new target for cardiovascular therapeutics.

Journal of the American College of Cardiology

Deedwania PC

ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collab

Journal of the American College of Cardiology

Crawford MH, Bernstein SJ, Deedwania PC, DiMarco JP, Ferrick KJ, Garson A, Green LA, Greene HL, Silka MJ, Stone PH, Tracy CM, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Gregoratos G, Russell RO, Ryan TH, Smith SC

ACC/AHA guidelines for ambulatory electrocardiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the guidelines for ambulatory el

Circulation

Crawford MH, Bernstein SJ, Deedwania PC, DiMarco JP, Ferrick KJ, Garson A, Green LA, Greene HL, Silka MJ, Stone PH, Tracy CM, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Gregoratos G, Russell RO, Ryan TJ, Smith SC

Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke.

Hypertension (Dallas, Tex. : 1979)

Hutchison SJ, Sudhir K, Sievers RE, Zhu BQ, Sun YP, Chou TM, Chatterjee K, Deedwania PC, Cooke JP, Glantz SA, Parmley WW

Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group.

Heart disease (Hagerstown, Md.)

Gradman AH, Lewin A, Bowling BT, Tonkon M, Deedwania PC, Kezer AE, Hardison JD, Cushing DJ, Michelson EL

Endothelin, the bad actor in the play: a marker or mediator of cardiovascular disease.

Journal of the American College of Cardiology

Deedwania PC

In-utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats.

Journal of the American College of Cardiology

Hutchison SJ, Glantz SA, Zhu BQ, Sun YP, Chou TM, Chatterjee K, Deedwania PC, Parmley WW, Sudhir K

Tophaceous pseudogout of the mitral valve.

The Annals of thoracic surgery

Moon MR, Fann JI, Deedwania PC, Ferguson R, Kosek JC, Burdon TA

The American College of Physicians guidelines for screening blood cholesterol levels: a commentary.

The American journal of medicine

Criqui MH, Kinosian B, Glick H, Deedwania PC, Krauss RM

The cardiovascular dysmetabolic syndrome.

The American journal of medicine

Fagan TC, Deedwania PC

The deadly quartet revisited.

The American journal of medicine

Deedwania PC

Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators.

The New England journal of medicine

Boden WE, O'Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zoble RG, Wexler LF, Kleiger RE, Pepine CJ, Ferry DR, Chow BK, Lavori PW

Antioxidant diet preserves endothelium-dependent vasodilatation in resistance arteries of hypercholesterolemic rabbits exposed to environmental tobacco smoke.

Journal of cardiovascular pharmacology

Schwarzacher SP, Hutchison S, Chou TM, Sun YP, Zhu BQ, Chatterjee K, Glantz SA, Deedwania PC, Parmley WW, Sudhir K

Effects of antioxidant vitamins C and E on atherosclerosis in lipid-fed rabbits.

Cardiology

Sun YP, Zhu BQ, Sievers RE, Norkus EP, Parmley WW, Deedwania PC

Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research Investigators.

Journal of the American College of Cardiology

Ferry DR, O'Rourke RA, Blaustein AS, Crawford MH, Deedwania PC, Carson PE, Pepine CJ, Thomas RG, Hlatky MA, Leppo JA, Iwane MK, Kleiger RE, Zoble RG, Dai H, Chow BK, Lavori PW, Boden WE

Effects of second-hand smoke and gender on infarct size of young rats exposed in utero and in the neonatal to adolescent period.

Journal of the American College of Cardiology

Zhu BQ, Sun YP, Sudhir K, Sievers RE, Browne AE, Gao L, Hutchison SJ, Chou TM, Deedwania PC, Chatterjee K, Glantz SA, Parmley WW

Role of beta blockade in the treatment of myocardial ischemia.

The American journal of cardiology

Deedwania PC, Carbajal EV

The progression from hypertension to heart failure.

American journal of hypertension

Deedwania PC

Lipoprotein(a) in patients who have non-insulin-dependent diabetes with and without coronary artery disease.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Ginier P, Deedwania P

Chronic dietary L-arginine prevents endothelial dysfunction secondary to environmental tobacco smoke in normocholesterolemic rabbits.

Hypertension (Dallas, Tex. : 1979)

Hutchison SJ, Reitz MS, Sudhir K, Sievers RE, Zhu BQ, Sun YP, Chou TM, Deedwania PC, Chatterjee K, Glantz SA, Parmley WW

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

Lancet (London, England)

Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI

Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta.

Journal of the American College of Cardiology

Hutchison SJ, Sudhir K, Chou TM, Sievers RE, Zhu BQ, Sun YP, Deedwania PC, Glantz SA, Parmley WW, Chatterjee K

Silent ischaemia: to treat or not to treat?

Indian heart journal

Deedwania PC

Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators.

Circulation

Massie BM, Fisher SG, Radford M, Deedwania PC, Singh BN, Fletcher RD, Singh SN

Anti-ischemic properties of ACE-inhibitors.

Cardiologia (Rome, Italy)

Deedwania PC

Hemodynamic variability and myocardial ischemia.

Cardiology clinics

Deedwania PC

Contemporary approaches in medical management of patients with stable coronary artery disease.

The Medical clinics of North America

Carbajal EV, Deedwania PC

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.

The New England journal of medicine

Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D

Mental stress, pain perception and risk of silent ischemia.

Journal of the American College of Cardiology

Deedwania PC

Randomized Placebo-Controlled Withdrawal Study of Amlodipine in Agina Pectoris.

American journal of therapeutics

Gorwit J, Haidet GC, Russell DC, Tonkon M, Deedwania PC, Borer JS

Triggers and timing of coronary events and sudden cardiac death.

Journal of the American College of Cardiology

Deedwania PC

Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)

Circulation

Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, Miller E, Marks RG, Thadani U

Is there evidence in support of the ischemia suppression hypothesis?

Journal of the American College of Cardiology

Deedwania PC

Predictors of mortality in patients with heart failure.

Cardiology clinics

Gradman AH, Deedwania PC

Prevalence and prognosis of heart failure.

Cardiology clinics

Deedwania PC

Does myocardial ischemia portend poor prognosis?

Journal of the American College of Cardiology

Deedwania PC

Information integration in a decision support system.

Proceedings. Symposium on Computer Applications in Medical Care

Hudson DL, Cohen ME, Deedwania PC

Veterans Affairs congestive heart failure antiarrhythmic trial. CHF STAT Investigators.

The American journal of cardiology

Singh SN, Fletcher RD, Fisher S, Lazzeri D, Deedwania P, Lewis D, Massie B, Singh BN, Colling C

Amlodipine once a day in stable angina: double-blind crossover comparison with placebo.

Clinical cardiology

Deedwania PC, Cheitlin MD, Das SK, Pool PE, Singh JB, Pasternak RC

Secondary prevention after myocardial infarction. Too many choices, which ones work?

Archives of internal medicine

Deedwania PC, Carbajal EV

Diagnostic and therapeutic implications: exploration through case discussions.

The American journal of cardiology

Jaffe AS, Deedwania PC, Higginson LA, Boden WE, Mehta JL, Ferlinz J, Walsh RA, Sullivan JM, Vokonas PS, Cabin H

Role of myocardial oxygen demand in the pathogenesis of silent ischemia during daily life.

The American journal of cardiology

Deedwania PC, Carbajal EV

Congestive heart failure: survival trial of antiarrhythmic therapy (CHF STAT). The CHF STAT Investigators.

Controlled clinical trials

Singh S, Fletcher RD, Fisher S, Deedwania P, Lewis D, Massie B, Singh B, Colling CL

Systemic and coronary hemodynamic effects of bepridil in patients with depressed left ventricular function.

The American journal of cardiology

De Marco T, Deedwania P, Chatterjee K

Silent myocardial ischemia. A clinical perspective.

Archives of internal medicine

Deedwania PC, Carbajal EV

Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia.

Journal of the American College of Cardiology

Deedwania PC, Carbajal EV, Nelson JR, Hait H

Double-blind crossover comparison of amlodipine at three dose levels and placebo in chronic stable angina.

American heart journal

Deedwania P, Cheitlin M, Das S, Pool P, Singh J, Pasternak R, Carabello B

Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group.

Journal of the American College of Cardiology

Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, Goldstein S

Effects of beta-adrenergic stimulation on atrial latency and atrial vulnerability in patients with paroxysmal supraventricular tachycardia.

The American journal of cardiology

Nguyen NX, Yang PT, Huycke EC, Keung EC, Deedwania P, Sung RJ

Similar efficacy of nitrendipine in young and elderly hypertensive patients.

The American journal of cardiology

Mehta J, Lopez LM, Deedwania PC, Fagan TC, Sternlieb CM, Vlachakis ND, Birkett JP, Schwartz LA

Beta blockers in combination with class I antiarrhythmic agents.

The American journal of cardiology

Deedwania PC, Olukotun AY, Kupersmith J, Jenkins P, Golden P

Current perspectives in treatment of angina pectoris.

Postgraduate medicine

Deedwania PC, Carbajal EV

Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.

Journal of cardiovascular pharmacology

Fagan TC, Sternleib C, Vlachakis N, Deedwania PC, Mehta JL

Calcium channel blockers.

The Western journal of medicine

Deedwania PC

Effect of age on atrioventricular conduction in patients with chronic bifascicular block.

The American journal of cardiology

Dhingra RC, Wyndham C, Deedwania PC, Bauernfeind R, Swiryn S, Best D, Rosen KM

Chronic intraventricular conduction defects.

Indian heart journal: teaching series

Deedwania PC, Dhingra RC

Significance of fascicular block complicating acute myocardial infarction.

Indian heart journal: teaching series

Dhingra RC, Deedwania PC

Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block.

Circulation

Dhingra RC, Wyndham C, Bauernfeind R, Swiryn S, Deedwania PC, Smith T, Denes P, Rosen KM

Nocturnal atrioventricular block as a manifestation of sleep apnea syndrome.

Chest

Deedwania PC, Swiryn S, Dhingra RC, Rosen KM

Electrophysiologic observations in a patient with bradycardia-dependent atrioventricular block.

The American journal of cardiology

Wu D, Deedwania P, Dhingra RC, Engleman RM, Rosen KM

Electrophysiologic effects of lidocaine on sinus node and atrium in patients with and without sinoatrial dysfunction.

Circulation

Dhingra RC, Deedwania PC, Cummings JM, Amat-Y-Leon F, Wu D, Denes P, Rosen KM

Sites of conduction disease in aortic stenosis: significance of valve gradient and calcification.

Annals of internal medicine

Dhingra RC, Amat-y-Leon F, Pietras RJ, Wyndham C, Deedwania PC, Wu D, Denes P, Rosen KM

A new approach for indirect recording of anterior left atrial activation in man.

American heart journal

Amat-y-Leon F, Deedwania P, Miller RH, Dhingra RC, Rosen KM

Clinical significance of prolonged sinoatrial conduction time.

Circulation

Dhingra RC, Amat-y-Leon F, Wyndham C, Deedwania PC, Wu D, Denes P, Rosen KM